4.7 Article

MxB Restricts HIV-1 by Targeting the Tri-hexamer Interface of the Viral Capsid

Journal

STRUCTURE
Volume 27, Issue 8, Pages 1234-+

Publisher

CELL PRESS
DOI: 10.1016/j.str.2019.04.015

Keywords

-

Funding

  1. NIH [P50GM082251, P30GM110758, R01-GM116961]
  2. Collaboration Development Pilot Program award from the Pittsburgh Center for HIV Protein Interactions
  3. Yale Predoctoral Training Program in Virology Training Program NIH [T32 AI055403]
  4. Predoctoral Program in Biophysics NIH [T32 GM008283]
  5. Interdisciplinary Immunology Training Program NIH [T32 AI007019]
  6. National Institute of General Medical Sciences from the NIH [P41 GM103403]
  7. NIH-ORIP HEI grant [S10 RR029205]
  8. DOE Office of Science [DE-AC02-06CH11357]

Ask authors/readers for more resources

The human antiviral protein MxB is a restriction factor that fights HIV infection. Previous experiments have demonstrated that MxB targets the HIV capsid, a protein shell that protects the viral genome. To make the conical-shaped capsid, HIV CA proteins are organized into a lattice composed of hexamer and pentamer building blocks, providing many interfaces for host proteins to recognize. Through extensive biochemical and biophysical studies and molecular dynamics simulations, we show that MxB is targeting the HIV capsid by recognizing the region created at the intersection of three CA hexamers. We are further able to map this interaction to a few CA residues, located in a negatively charged well at the interface between the three CA hexamers. This work provides detailed residue-level mapping of the targeted capsid interface and how MxB interacts. This information could inspire the development of capsid-targeting therapies for HIV.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available